US Government Backs Hikma In Vascepa Skinny Label Case, Suggests SCOTUS Review

 
• By Dean Rudge
  
US Supreme Court interior
The Hikma Vascepa case could have significant implications on the generic industry. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from United States